These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24171919)

  • 1. Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.
    Tepel M; Armbruster FP; Grön HJ; Scholze A; Reichetzeder C; Roth HJ; Hocher B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4744-51. PubMed ID: 24171919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.
    Hocher B; Oberthür D; Slowinski T; Querfeld U; Schaefer F; Doyon A; Tepel M; Roth HJ; Grön HJ; Reichetzeder C; Betzel C; Armbruster FP
    Kidney Blood Press Res; 2013; 37(4-5):240-51. PubMed ID: 23868100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients.
    Lu YP; Zeng S; Chu C; Hasan AA; Slowinski T; Yin LH; Krämer BK; Hocher B
    Clin Chim Acta; 2020 Sep; 508():92-97. PubMed ID: 32413401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
    Ursem SR; Vervloet MG; Hillebrand JJG; de Jongh RT; Heijboer AC
    Clin Chem Lab Med; 2018 Jan; 56(2):249-255. PubMed ID: 28809747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.
    Zuo J; Hasan AA; Hocher CF; Kalk P; Kleuser B; Krämer BK; Hocher B
    Front Endocrinol (Lausanne); 2023; 14():1178166. PubMed ID: 37324252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary Hyperparathyroidism.
    Hocher B; Yin L
    Nephron; 2017; 136(2):137-142. PubMed ID: 28183082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.
    Zeng S; Querfeld U; Feger M; Haffner D; Hasan AA; Chu C; Slowinski T; Bernd Dschietzig T; Schäfer F; Xiong Y; Zhang B; Rausch S; Horvathova K; Lang F; Karl Krämer B; Föller M; Hocher B
    FASEB J; 2020 Nov; 34(11):15269-15281. PubMed ID: 32964520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.
    Cozzolino M; Brancaccio D; Cannella G; Messa P; Gesualdo L; Marangella M; LoDeserto C; Pozzato M; Rombolà G; Costanzo AM; di Luzio Paparatti U; Mazzaferro S;
    Nephrol Dial Transplant; 2012 Sep; 27(9):3588-94. PubMed ID: 22523119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin - evidence from in vitro and human studies.
    Li M; Hasan AA; Chu C; Hocher JG; Liu Y; Zhang X; Chen X; Yard B; Krämer BK; Hocher B
    Pflugers Arch; 2024 Jun; 476(6):889-899. PubMed ID: 38393416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
    Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients.
    Villa-Bellosta R; Rodriguez-Osorio L; Mas S; Abadi Y; Rubert M; de la Piedra C; Gracia-Iguacel C; Mahillo I; Ortiz A; Egido J; González-Parra E
    PLoS One; 2017; 12(3):e0173831. PubMed ID: 28339474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.
    Scholze A; Rattensperger D; Zidek W; Tepel M
    Obesity (Silver Spring); 2007 Jun; 15(6):1617-22. PubMed ID: 17558000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.